Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry
- PMID: 9927426
- PMCID: PMC1171159
- DOI: 10.1093/emboj/18.3.664
Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry
Abstract
Mitogen-activated protein kinase (MAPK) modules, composed of three protein kinases activated by successive phosphorylation, are involved in the signal transduction of a wide range of extracellular agents. In mammalian cells, mitogenic stimulation triggers the translocation of p42/p44MAPK from the cytoplasm to the nucleus, whereas the other protein kinases of the module remain cytosolic. Since MAPK has been shown to phosphorylate and activate nuclear targets, such as the transcription factor Elk1, it has been proposed, but not yet demonstrated, that MAPK nuclear translocation could represent a critical step in signal transduction. In this study, we sequestered p42/p44MAPK in the cytoplasm by the expression of a catalytically inactive form of cytoplasmic MAP kinase phosphatase (MKP-3/Pyst-1). Sequestering MAPK in the cytoplasm did not alter its activation or its ability to phosphorylate cytoplasmic substrates of MAPK (p90RSK1 or an engineered cytoplasmic form of Elk1). In contrast, prevention of MAPK nuclear translocation strongly inhibited Elk1-dependent gene transcription and the ability of cells to reinitiate DNA replication in response to growth factors. Thus the relocalization of MAPK to the nucleus appears to be an important regulatory step for mitogen-induced gene expression and cell cycle re-entry.
Similar articles
-
Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice.J Cell Physiol. 2004 Jun;199(3):441-50. doi: 10.1002/jcp.10465. J Cell Physiol. 2004. PMID: 15095291
-
Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.Biochem J. 2000 Nov 15;352 Pt 1(Pt 1):155-63. Biochem J. 2000. PMID: 11062068 Free PMC article.
-
[MAP kinase module: role in the control of cell proliferation].C R Seances Soc Biol Fil. 1995;189(1):43-57. C R Seances Soc Biol Fil. 1995. PMID: 7648366 Review. French.
-
Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.Eur J Pharmacol. 2006 Jul 17;541(3):138-46. doi: 10.1016/j.ejphar.2006.05.002. Eur J Pharmacol. 2006. PMID: 16765938
-
Mammalian MAP kinase modules: how to transduce specific signals.Essays Biochem. 1997;32:1-16. Essays Biochem. 1997. PMID: 9493007 Review.
Cited by
-
ERK2 Is a Promoter of Cancer Cell Growth and Migration in Colon Adenocarcinoma.Antioxidants (Basel). 2024 Jan 17;13(1):119. doi: 10.3390/antiox13010119. Antioxidants (Basel). 2024. PMID: 38247543 Free PMC article.
-
Extracellular Signal-Regulated Kinases: One Pathway, Multiple Fates.Cancers (Basel). 2023 Dec 24;16(1):95. doi: 10.3390/cancers16010095. Cancers (Basel). 2023. PMID: 38201521 Free PMC article. Review.
-
The interplay between cell wall integrity and cell cycle progression in plants.Plant Mol Biol. 2023 Dec;113(6):367-382. doi: 10.1007/s11103-023-01394-w. Epub 2023 Dec 13. Plant Mol Biol. 2023. PMID: 38091166 Free PMC article. Review.
-
A guide to ERK dynamics, part 2: downstream decoding.Biochem J. 2023 Dec 13;480(23):1909-1928. doi: 10.1042/BCJ20230277. Biochem J. 2023. PMID: 38038975 Free PMC article.
-
A guide to ERK dynamics, part 1: mechanisms and models.Biochem J. 2023 Dec 13;480(23):1887-1907. doi: 10.1042/BCJ20230276. Biochem J. 2023. PMID: 38038974 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous